B
Bull
Bull · 25%AMED
$104.36
Szenariopreis
$100.990
+0.010 (+0.01%)Zum Schluss
Loading chart…
- High
- 101.020
- Open
- 101.020
- VWAP
- 100.98
- Vol
- 1.06M
- Mkt Cap
- 3.04B
- Low
- 100.930
- Amount
- 107.04M
- EV/EBITDA, TTM
- 12.17
Amedisys, Inc. is a healthcare services company. It provides in-home healthcare and related services to the chronic, co-morbid and aging American population. Its segments include home health, hospice and high acuity care. Its home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Its nurses administer medications, care for wounds, monitor vital signs and provide a range of other nursing services. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, palliative and skilled nursing facility care to patients in their homes. It owns and operates 347 Medicare-certified home health care centers, 164 Medicare-certified hospice care centers and eight admitting high acuity care joint ventures in 38 states within the United States and the District of Columbia.
Analyst Ratings (11)
+2.24% upside
Hold
5 Buy
6 Hold
0 Sell
Current: 100.99
Tief
101.00
Durchschnitt
103.25
Hoch
110.00
RBC Capital
Buy
$100
2025-04-16
RBC Capital
2025-04-16
Kursziel
$100
Buy
Stephens & Co.
Hold
$101
2025-03-04
Stephens & Co.
2025-03-04
Kursziel
$101
Hold
Stephens & Co.
Hold
$101
2025-02-12
Stephens & Co.
2025-02-12
Kursziel
$101
Hold
Deutsche Bank
Hold
$101
2024-07-31
Deutsche Bank
2024-07-31
Kursziel
$101
Hold
Cantor Fitzgerald
Hold
$101
2024-07-25
Cantor Fitzgerald
2024-07-25
Kursziel
$101
Hold
Bewertungskennzahlen
The current forward P/E ratio for Amedisys Inc (AMED) is 18.61, compared to its 5-year average forward P/E of 21.86.
Alphio AI Price Scenarios for AMED
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Event-Zeitleiste
News
5.008-15BenzingaWhy Is UnitedHealth Stock Trading Higher Friday?
2.008-15SeekingAlphaTwilio set to join S&P MidCap 400
8.008-14BenzingaUnitedHealth Group Climbs 1.17% After Hours Following $2.21 Quarterly Dividend Authorization
8.508-11BenzingaWhat's Going On With UnitedHealth Stock Monday?
8.508-08BenzingaUnitedHealth Faces Large Outpatient Divestiture To Resolve Antitrust Suit Related To Amedisys Deal
AMED FAQ — answered by Alphio AI
Amedisys, Inc. is a healthcare services company. It provides in-home healthcare and related services to the chronic, co-morbid and aging American population. Its segments include home health, hospice and high acuity care. Its home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Its nurses administer medications, care for wounds, monitor vital signs and provide a range of other nursing services. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, palliative and skilled nursing facility care to patients in their homes. It owns and operates 347 Medicare-certified home health care centers, 164 Medicare-certified hospice care centers and eight admitting high acuity care joint ventures in 38 states within the United States and the District of Columbia. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).
11 analysts cover AMED: 5 rate it Buy, 6 Hold and 0 Sell. The average price target is 103.25.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.